Selvita Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 900
Employees
  • Stock Symbol
  • SLV
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $17.50
  • (As of Thursday Closing)

Selvita General Information

Description

Selvita SA is a Poland based company focused on the areas of drug discovery, regulatory studies, as well as research and development.

Contact Information

Website
www.selvita.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Stock Exchange
WAR
Primary Office
  • Park Life Science
  • Bobrzynskiego 14
  • Krakow, 30-348
  • Poland
+48 12 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Selvita Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.50 $17.38 $13.16 - $22.32 $321M 18.4M 11.8K $0.21

Selvita Financials Summary

In Thousands,
USD 		TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2018 31-Dec-2018
EV 391,217 391,217 228,576
Revenue 80,482 80,482 35,221 19,559
EBITDA 13,549 13,549 8,461 4,479
Net Income 3,857 3,857 4,615 2,905
Total Assets 114,874 114,874 58,716 19,288
Total Debt 44,266 44,266 11,071 2,014
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Selvita Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Selvita‘s full profile, request access.

Request a free trial

Selvita Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Selvita SA is a Poland based company focused on the areas of drug discovery, regulatory studies, as well as research and
Drug Discovery
Krakow, Poland
900 As of 2022
000.00
000000000 000.00

00000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000 000000000
Nottingham, United Kingdom
000 As of 0000
00000000000

00000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostru
0000 000000000
San Carlos, CA
00 As of 0000
00000
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Selvita Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom 000 00000000000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 000000000000 00000
00000000 Formerly VC-backed San Diego, CA 000 00000 000000&0 00000
00000 00000000000 Formerly VC-backed Hayward, CA 000 00000 000000000 00000
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

Selvita Patents

  • 43

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Selvita Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180305331-A1 Pyridone derivatives and their use as kinase inhibitors Abandoned 22-Oct-2015 0000000000
AU-2016341259-A1 Pyridone derivatives and their use as kinase inhibitors Granted 22-Oct-2015 0000000000
AU-2016341259-B2 Pyridone derivatives and their use as kinase inhibitors Expired - Fee Related 22-Oct-2015 0000000000 0
CA-3002875-A1 Pyridone derivatives and their use as kinase inhibitors Abandoned 22-Oct-2015 0000000000
JP-2018531266-A Pyridone derivatives and their use as kinase inhibitors Ceased 22-Oct-2015 C07D401/04 0
To view Selvita’s complete patent history, request access »

Selvita Executive Team (12)

Name Title Board Seat Contact Info
Bogusław Sieczkowski Co-Founder & Chief Executive Officer
Dariusz Kurdas Chief Financial Officer
Mirosława Zydroń Chief Operating Officer
Miłosz Gruca Chief Commercial Officer & Executive Vice President
Andrzej Nieradka Manager, Business Development
You’re viewing 5 of 12 executive team members. Get the full list »

Selvita Board Members (1)

Name Representing Role Since
00000 0000000000000000 Self Board Member 000 0000
To view Selvita’s complete board members history, request access »

Selvita Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Selvita Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Selvita‘s full profile, request access.

Request a free trial

Selvita Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 04-Jan-2021 0000000000 000.00 Drug Discovery
0000000000 21-Oct-2010 000000000 Biotechnology 00000ł00
BioCentrum 31-Mar-2008 Merger/Acquisition Biotechnology 00000 000
To view Selvita’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Selvita Subsidiaries (2)

Company Name Industry Location Founded
Fidelta Drug Discovery Zagreb, Croatia 2013
0000000000 Biotechnology Krakow, Poland 0000
To view Selvita’s complete subsidiaries history, request access »